[Effect of heptapeptide semax on the cardiac activity in acute hypobaric hypoxia during the early postnatal period].
Maslova
M V
MV
Krushinskaia
Ia V
IaV
Maklakova
A S
AS
Balan
P V
PV
Kuznetsov
Iu B
IuB
Sokolova
N A
NA
Ashmarin
I P
IP
D000208:Acute Disease; D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000818:Animals; D000831:Animals, Newborn; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001274:Atmospheric Pressure; D001919:Bradycardia / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D004562:Electrocardiography; D005260:Female; D000860:Hypoxia / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D051381:Rats
D000889:Anti-Arrhythmia Agents; D010446:Peptide Fragments; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone